Why the study?
Obesity is associated with structural and functional brain changes with inflammation as a potential mechanism, but the relationship between serum BDNF, obesity predictor markers, and inflammation levels in females with obesity required evaluation.
Does serum BDNF level correlate with obesity predictor markers and inflammation levels in females with obesity?
Does serum BDNF level correlate with obesity predictor markers and inflammation levels in females with obesity?
Serum BDNF levels are negatively correlated with BMI, waist-to-hip ratio, and inflammatory markers (IL-6, TNF-alpha) in young females with obesity.
Supports BDNF-obesity link in young females; hypothesis-generating, should not change practice.
BACKGROUND: Obesity has been widely associated with structural and functional changes in the brain, whereas inflammation is one of the potential mechanisms involved in these changes. OBJECTIVE: This study aims to prove the relationship between serum brain-derived neurotrophic factor (BDNF) levels and obesity predictor markers (body mass index and waist to hip ratio) and inflammation (interleukin-6 and Tumor Necrosis Factor-alpha) levels in females with obesity. METHODS: This study used a cross-sectional study method using 33 females with obesity aged 19-23 years, body mass index (BMI) > 27.5 kg/m2, normal blood pressure, normal resting heart rate (RHR), normal hemoglobin (Hb), and fasting blood glucose (FBG) ≤ 100 mg/dL. The examination of serum BDNF, IL-6, and TNF-α levels using the Enzyme-Linked Immunosorbent Assay (ELISA) method. The data were analyzed using Pearson product-moment test with a significant levels p<0.05. RESULTS: The results indicated that there is a negative correlation between serum BDNF levels and BMI (r = –0.759; p<0.001), WHR (r = –0.675; p<0.001), IL-6 levels (r = –0.530; p<0.001) and TNF-α levels (r = –0.561; p<0.001). CONCLUSION: Based on the results of the study, there is a negative correlation between serum BDNF levels and BMI, waist to hip ratio, and inflammation (interleukin-6 and Tumor Necrosis Factor-alpha) levels in females with obesity. Further studies are needed to confirm the present findings.
No takes yet. Share an insight, caveat, or question.
Raharjo et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: